Remove Diabetes Remove Obesity Remove Risk Factors
article thumbnail

Predicting Cardiovascular Disease in Patients Without Risk Factors with Matthew Budoff, MD

HCPLive

Budoff, MD Fact checked by: Ryan Livingston Conference | Heart in Diabetes Budoff suggests monitoring serum lipoproteins like Lp(a) and ApoB to predict cardiovascular disease risk in patients with no conventional indicators. Among these, Budoff and colleagues noted that Lp(a) was the most consistent predictor of atherosclerosis. “It

article thumbnail

Classifying Obesity as a Chronic Disease with W. Timothy Garvey, MD

HCPLive

Timothy Garvey, MD Fact checked by: Ryan Livingston Conference | Heart in Diabetes The recent Lancet Commission on Obesity has repositioned the former risk factor as a disease, indicating and emphasizing a variety of complications. At the 9 th Annual Heart in Diabetes Conference in Philadelphia, PA, W.

article thumbnail

Depression Linked to Poor Cardiovascular Outcomes in Spontaneous Coronary Artery Dissection

HCPLive

Abena Korwaa Agyekum, MD Credit: X.com Comorbid depression in patients with spontaneous coronary artery dissection (SCAD) is linked to a significantly increased risk of several adverse cardiovascular outcomes, according to findings from a recent study. American Heart Association. Coronary Artery Dissection: Not Just a Heart Attack.

article thumbnail

Research status of triglyceride glucose-body mass index (TyG-BMI index)

Frontiers in Cardiovascular Medicine

Insulin resistance (IR) represents a pivotal metabolic risk factor, with metabolic abnormalities intricately linked to increased predisposition to cardiovascular, digestive, and immune system disorders.

BMI
article thumbnail

The role of VAP-1 in cardiovascular disease: a review

Frontiers in Cardiovascular Medicine

Cardiovascular diseases (CVD) remain the primary cause of morbidity and mortality in developed countries, highlighting the urgent need to identify biomarkers associated with CVD and its risk factors. Notably, elevated plasma VAP-1 activity has been observed in patients with CVD and diabetes.

article thumbnail

Association of obesity- and insulin resistance-related indices with subclinical carotid atherosclerosis in type 1 diabetes: a cross-sectional study

Cardiovascular Diabetology

Obesity and insulin resistance are well-established risk factors for atherosclerosis and cardiovascular disease (CVD). Although some obesity- and insulin resistance-related indices (OIRIs) have been linked to.

article thumbnail

Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective

Frontiers in Cardiovascular Medicine

GLP-1 RAs have been used for diabetes and found to improve CV outcomes in diabetic and nondiabetic patients. They are authorized for treating obesity. IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits.